NovaDigm Therapeutics has started a Phase Ib/IIa clinical trial of its NDV-3 vaccine, which is being developed to prevent episodes of vulvovaginal candidiasis (VVC) in patients with recurrent VVC (RVVC). Under the trial, which is a ...
Tags: NDV-3 Vaccine, NovaDigm
US-based biopharmaceutical company NovaRx will present the results from the Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer at the European Society for Medical Oncology (ESMO) ...
Tags: Novarx, Therapeutic Vaccine Trial
British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
Biotechnology company Bharat Biotech has introduced world's first clinically proven typhoid conjugate vaccine, Typbar-TCV, to protect infants aged six months and more and adults from typhoid fever caused by Salmonella typhi. Commercial ...
Tags: Bharat Biotech, Vaccine
The Indonesian Ministry of Health is planning to launch a new immunization program and a pentavalent vaccine for infants two months old to one year. Produced by Bio Farma, the pentavalent vaccine is a combination of five antigens ...
Tags: Immunization Program, Infants
Biopharmaceutical company Galena Biopharma has announced patent notification from the European Patent Office for pharmaceutical use of NeuVax (nelipepimut-S) as a vaccine for the prevention of relapse in breast cancer patients. The patent ...
Tags: Galena Biopharma, Neuvax
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Flulaval Quadrivalent (Influenza Virus Vaccine) for the active immunization of people three years of age and more to help prevent disease caused by seasonal influenza ...
Tags: Flulaval Quadrivalent
The Australian Therapeutic Goods Administration (TGA) has granted approval for Novartis' multi-component Meningococcal B (MenB) vaccine, Bexsero, for use against a dangerous form of bacterial meningitis, MenB disease. The approval will ...
Tags: Menb Disease, Medicine
Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific, has signed a licensing deal with Benitec Biopharma for ddRNAi gene silencing technology to develop vaccines. Regen will apply ddRNAi to silence indoleamine 2,3 -- ...
Tags: Regen BioPharma, Medicine
Pharmaceutical and healthcare company GlaxoSmithKline (GSK) will roll out two-dimensional (2D) barcodes on the inner containers as well as outer boxes for most of its US vaccines. According to the company, a 2D barcode is a small square ...
Tags: GlaxoSmithKline, 2D Barcodes
British drugmaker GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for its cervical cancer vaccine, Cervarix [Human papillomavirus bivalent (types 16 and 18) vaccine, ...
Tags: Cervarix, Schedule Application
The US Food and Drug Administration (FDA) has approved the supply of GlaxoSmithKline's four-strain (quadrivalent) influenza vaccine, Fluarix Quadrivalent, to CDC distribution centers and healthcare providers in the US. Fluarix ...
The US Food and Drug Administration (FDA) has expanded age indication for Novartis' Menveo (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) to include infants and toddlers aged two months and ...
GlaxoSmithKline (GSK) is mulling to establish a joint venture (JV) with a Chinese company as part of its vaccine strategy of teaming up with local partners. The plans come at a time when the company is facing corruption and tax laws ...
Tags: Vaccine Research, GSK
Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...
Tags: Pneumococcal Vaccine, Medicine